Baidu
map

BD Mission活检产品在华首发 为我国精准诊疗护航

2019-01-18 美通社 美通社

今日,全球领先的医疗技术公司BD公司宣布,一次性穿刺活检针 BD Mission 在华首发。Mission凭借实时可控、操作随心、取样饱满的独特优势,将更安全和更高效地满足临床在活检穿刺方面日益增多的需求。BD Mission 活检产品在华首发从指南到临床实践,经皮活检价值获广泛认可今日,全球领先的医疗技术公司BD公司宣布,一次性穿刺活检针 BD Mission 在华首发。对于大多数恶性肿瘤而

今日,全球领先的医疗技术公司BD公司宣布,一次性穿刺活检针 BD Mission 在华首发。Mission凭借实时可控、操作随心、取样饱满的独特优势,将更安全和更高效地满足临床在活检穿刺方面日益增多的需求。

BD Mission 活检产品在华首发
BD Mission 活检产品在华首发

从指南到临床实践,经皮活检价值获广泛认可

今日,全球领先的医疗技术公司BD公司宣布,一次性穿刺活检针 BD Mission 在华首发。

对于大多数恶性肿瘤而言,病理诊断是“金标准”,只有通过活检收集患者细胞或组织进行病理检查后才能获得明确诊断。超声引导下的穿刺活检和介入治疗,能够以最小的创伤为患者解除病患,为临床提供宝贵的诊断信息。中国医师协会超声医师分会会长、首都医科大学附属北京天坛医院超声科主任何文教授在视频寄语中提到,介入性超声是超声医学的重要组成部分,在临床上发挥的作用越来越重要。

中华医学会外科学分会常委、乳腺外科学组组长、北京大学第一医院乳腺疾病中心教授刘荫华教授指出,乳腺组织病理诊断是乳腺癌诊断标准,经皮空芯针穿刺是目前最重要的诊断方法。除了明确乳腺肿块良恶性,对已确诊乳腺癌的患者,生物学指标检测可以指导药物选择;保乳手术前活检利于术式选择及确定手术切除范围。

中国抗癌协会肿瘤介入学专业委员会主任委员、北京大学第一医院介入血管外科主任邹英华教授表示肺癌在全球及我国的发病率、死亡率均位居首位。目前肿瘤治疗中,如化疗、免疫及靶向治疗都离不开组织活检,CT引导下经皮肺穿刺活检能够提供足够的组织以明确肺部肿块良、恶性,避免不必要的手术治疗,足够的分子基因型分析为有针对性的靶向治疗提供最佳的治疗方案。

随着影像设备的发展,经皮穿刺活检的临床应用范围不断拓展,不仅可以获得病理组织亚型分类还可以进行基因检测,准确率高达90%以上。

活检产品迭代,助力诊疗技术基层推广和分级

2016年12月,在国务院印发的《“十三五”深化医药卫生体制改革规划》中提出,“十三五”期间,要在分级诊疗、现代医院管理、全民医保、药品供应保障、综合监管等5项制度建设上取得新突破,同时统筹推进相关领域改革。介入性超声技术的基层普及和推广是提高基层诊疗能力、落实分级诊疗制度的技术支撑,也是基层医疗机构的迫切需求。

中国医师协会超声医师分会常委兼总干事、解放军总医院超声科主任罗渝昆教授介绍通过穿刺活检,能获得明确的病理诊断依据,指导临床医生制定最佳治疗方案,尤其对肿瘤的早发现、早诊断、早治疗起到了非常重要的作用。与全自动活检针不同,半自动活检针可先手动推至目标位置,然后再击发取样,活检过程中针尖及取样槽的位置在超声下清晰可见、能够实时精准地控制针尖,避免发生偏移、损伤周围重要结构,提高了活检操作的安全性和取样位置的准确性;其次,半自动轻便、小巧,极大地方便了超声医师的单手操作。这些特性有利于年轻医生掌握活检技术以及该技术的基层推广,对促进分级诊疗制度有重要意义。

BD中国活检&泌尿及重症监护高级业务总监刘士强先生介绍说,针对中国市场的特殊需求,我们与国内的专业协会合作,在中国进行介入诊疗的专业教育。未来三年BD公司将继续与中国抗癌协会肿瘤介入学组、中国医师协会超声医师分会及中华医学会乳腺学组合作推动相关项目。此外,在介入诊疗领域,BD公司一直不断研发和创新产品以满足不同患者的需求,2020年和2021年也将在中国分别上市另外两款新的活检针,为中国的介入诊疗事业发展做出切实的贡献。

BD Mission 随心而动 精准碧达

BD Mission 新品发布媒体沟通环节
BD Mission 新品发布媒体沟通环节

Mission采用304不锈钢材质及锋利的针尖,穿透性强,并继承BD优质弹簧,切割有力,保证样本饱满稳定。Mission匹配一次性同轴活检针,可以达到一点穿刺,多次取样,提升操作效率,极大减少气胸等并发症,而且钝头内芯针可减少血管和重要脏器损伤。Mission的这些独特设计,使得超声及CT引导下的经皮软组织活检能安全、高效地获得满意样本。中国医师协会介入医师分会急诊介入专业委员会主任委员、湖南省人民医院副院长向华教授在视频寄语中表示,肺部穿刺活检为我们提供很好的病理诊断、亚组织分型及基因诊断,在临床上的作用越来越大,它有足够的安全性、足够的病理组织量,为肿瘤诊断提供很好的临床依据,很欣慰看到越来越好的活检针产品用在肿瘤的穿刺活检中造福更多的肿瘤患者。

在上市会上,来自香港大学放射诊断学院荣誉副教授、香港养和医院放射诊断专家Wong Kim Ping Rex通过视频连线的形式,与大家分享了CT引导下经皮肺活检操作并利用诸多临床案例呈现了肺活检操作中的关键要点,在涉及到对靠近主动脉的小病灶实施活检时,特别提到半自动活检针可调节的取样深度、零射程、能够准确控制进针深度,非常安全。

我国精准诊疗的“护航舰”

Mission具备取样位置精准、样本饱满稳定,还可以根据病灶大小选择取样深度,独特的人体工程学设计使得操作简单便捷,能够全方位满足医生的需求,必将成为我国精准诊疗的“护航舰”。

BD Mission将成为我国精准诊疗的“护航舰”
BD Mission将成为我国精准诊疗的“护航舰”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2068352, encodeId=82fd206835284, content=<a href='/topic/show?id=25de11958df' target=_blank style='color:#2F92EE;'>#MISSION#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11958, encryptionId=25de11958df, topicName=MISSION)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Nov 22 08:37:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649429, encodeId=f3001649429e8, content=<a href='/topic/show?id=081a16e10e8' target=_blank style='color:#2F92EE;'>#SSI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16710, encryptionId=081a16e10e8, topicName=SSI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=586523824746, createdName=nymo, createdTime=Mon Jul 29 17:37:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934099, encodeId=831d1934099c6, content=<a href='/topic/show?id=6686e63993d' target=_blank style='color:#2F92EE;'>#精准诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76399, encryptionId=6686e63993d, topicName=精准诊疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Jul 13 07:37:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278119, encodeId=302312e811956, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403380, encodeId=48c6140338080, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2068352, encodeId=82fd206835284, content=<a href='/topic/show?id=25de11958df' target=_blank style='color:#2F92EE;'>#MISSION#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11958, encryptionId=25de11958df, topicName=MISSION)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Nov 22 08:37:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649429, encodeId=f3001649429e8, content=<a href='/topic/show?id=081a16e10e8' target=_blank style='color:#2F92EE;'>#SSI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16710, encryptionId=081a16e10e8, topicName=SSI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=586523824746, createdName=nymo, createdTime=Mon Jul 29 17:37:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934099, encodeId=831d1934099c6, content=<a href='/topic/show?id=6686e63993d' target=_blank style='color:#2F92EE;'>#精准诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76399, encryptionId=6686e63993d, topicName=精准诊疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Jul 13 07:37:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278119, encodeId=302312e811956, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403380, encodeId=48c6140338080, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
    2019-07-29 nymo
  3. [GetPortalCommentsPageByObjectIdResponse(id=2068352, encodeId=82fd206835284, content=<a href='/topic/show?id=25de11958df' target=_blank style='color:#2F92EE;'>#MISSION#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11958, encryptionId=25de11958df, topicName=MISSION)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Nov 22 08:37:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649429, encodeId=f3001649429e8, content=<a href='/topic/show?id=081a16e10e8' target=_blank style='color:#2F92EE;'>#SSI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16710, encryptionId=081a16e10e8, topicName=SSI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=586523824746, createdName=nymo, createdTime=Mon Jul 29 17:37:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934099, encodeId=831d1934099c6, content=<a href='/topic/show?id=6686e63993d' target=_blank style='color:#2F92EE;'>#精准诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76399, encryptionId=6686e63993d, topicName=精准诊疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Jul 13 07:37:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278119, encodeId=302312e811956, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403380, encodeId=48c6140338080, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2068352, encodeId=82fd206835284, content=<a href='/topic/show?id=25de11958df' target=_blank style='color:#2F92EE;'>#MISSION#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11958, encryptionId=25de11958df, topicName=MISSION)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Nov 22 08:37:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649429, encodeId=f3001649429e8, content=<a href='/topic/show?id=081a16e10e8' target=_blank style='color:#2F92EE;'>#SSI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16710, encryptionId=081a16e10e8, topicName=SSI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=586523824746, createdName=nymo, createdTime=Mon Jul 29 17:37:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934099, encodeId=831d1934099c6, content=<a href='/topic/show?id=6686e63993d' target=_blank style='color:#2F92EE;'>#精准诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76399, encryptionId=6686e63993d, topicName=精准诊疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Jul 13 07:37:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278119, encodeId=302312e811956, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403380, encodeId=48c6140338080, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2068352, encodeId=82fd206835284, content=<a href='/topic/show?id=25de11958df' target=_blank style='color:#2F92EE;'>#MISSION#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11958, encryptionId=25de11958df, topicName=MISSION)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Nov 22 08:37:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649429, encodeId=f3001649429e8, content=<a href='/topic/show?id=081a16e10e8' target=_blank style='color:#2F92EE;'>#SSI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16710, encryptionId=081a16e10e8, topicName=SSI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=586523824746, createdName=nymo, createdTime=Mon Jul 29 17:37:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934099, encodeId=831d1934099c6, content=<a href='/topic/show?id=6686e63993d' target=_blank style='color:#2F92EE;'>#精准诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76399, encryptionId=6686e63993d, topicName=精准诊疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Jul 13 07:37:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278119, encodeId=302312e811956, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403380, encodeId=48c6140338080, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Sun Jan 20 11:37:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]

相关资讯

Circulation:炎症学说开创者Peter Libby提出精准诊疗急性冠脉综合征:根据炎症和影像学可分四种类型

动脉粥样硬化炎症学说的开创者Peter Libby最近在Circualtion杂志发表了一篇重要文章。

惠汝太:中国启动猝死相关心血管疾病精准诊疗系列研究

中华医学会心血管病学分会精准心血管病学学组组长惠汝太教授近期报告,我国已启动猝死相关心血管疾病精准诊疗系列研究——肥厚型心肌病多中心注册研究。

聚焦卵巢癌精准诊疗发展:BRCA基因检测率低,精准诊疗水平待提高

6月23日,《2017年精准诊疗下卵巢癌认知及患者生存现状调研》(以下简称调研)结果发布会在广州召开。此次调研由中国抗癌协会发起,阿斯利康中国支持,全国19个省市的上千名患者和近百名医生参与完成。会上,中国抗癌协会副秘书长、陆军总医院刘端祺教授,中山大学附属肿瘤医院曾木圣教授,中国抗癌协会妇科肿瘤专业委员会主委、重庆市肿瘤医院周琦教授分别致辞。中山大学附属肿瘤医院刘继红教授作为此次调研的主要研究者

论甲状腺癌精准诊疗

2018头颈肿瘤多学科诊治高峰论坛暨第一届甲状腺癌精准诊治培训班在北京隆重召开,此次大会聚集了众多头颈肿瘤尤其是甲状腺癌领域国际国内权威专家。泛生子基因在大会期间举办“泛生子甲状腺癌分子诊疗卫星会”,邀请到此次大会主席、北京大学肿瘤医院张彬教授作为卫星会主席,美国约翰霍普金斯大学医学院的邢明照教授作为特邀嘉宾,并在会议上讲演。浙江省人民医院雷科锋教授、北京大学肿瘤医院宋韫韬教授、北京泛生子基因科技

127家三甲医院组成中国静脉介入联盟

9月22日,127家三级医院组成的中国静脉介入联盟正式成立,这也标志我国静脉疾病开始进入多学科协作和精准诊疗时代。

Baidu
map
Baidu
map
Baidu
map